Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$37.76 USD
+0.48 (1.29%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $37.75 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Price, Consensus and EPS Surprise
HRMY 37.76 +0.48(1.29%)
Will HRMY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for HRMY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HRMY
HRMY or REGN: Which Is the Better Value Stock Right Now?
Is Harmony Biosciences (HRMY) a Great Value Stock Right Now?
HRMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock
Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect?
HRMY vs. REGN: Which Stock Is the Better Value Option?
Other News for HRMY
Harmony Biosciences management to meet with Needham
UBS starts Harmony Biosciences with Buy on Wakix growth
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
‘Bottom-fishing’ ideas within Piper Sandler’s universe of stocks
Harmony Biosciences: Unnoticed Melodies Of Portfolio Growth And Pipeline Potential